FindTrial
Sign In

Application of 16SrRNA sequencing technology in diagnosis of wound infection of autoimmune diseases

Application of 16SrRNA sequencing technology in diagnosis of wound infection of autoimmune diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048533
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune disease

Interventions

Gold Standard:Traditional culture or blood culture is positive, and it is identified by bacterial identification instrument
Index test:Bacterial&#32
culture&#32
is&#32
positive&#32
or&#32
target&#32
band&#32
amplified

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of rheumatology and immunology is confirmed as autoimmune disease; 2. Wound infection and ulceration occur.

Exclusion criteria

Exclusion criteria: 1. Poor compliance, not cooperating with the test; 2. Incomplete clinical data; 3. Complicated with other infections.

Design outcomes

Primary

MeasureTime frame
Detection of pathogenic bacteria;—

Countries

China

Contacts

Public ContactWang Li

Chengdu Women's and Children's Central Hospital

952071332@qq.com+86 18228055234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026